Production (Stage)
Cyclacel Pharmaceuticals, Inc.
CYCC
$0.3544
-$0.0577-14.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 23.30% | -7.13% | -49.83% | -40.97% | -75.53% |
| Total Receivables | -- | -- | -50.61% | -50.13% | -78.04% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -78.72% | -70.08% | -45.95% | -56.31% | -60.22% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -46.85% | -12.02% | -84.15% | -86.28% | -38.66% |
| Total Current Assets | -23.19% | -50.64% | -55.79% | -49.61% | -74.52% |
|
|
|||||
| Total Current Assets | -23.19% | -50.64% | -55.79% | -49.61% | -74.52% |
| Net Property, Plant & Equipment | -76.74% | -92.16% | -56.00% | -52.70% | -49.41% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -67.28% | -67.20% | -58.70% | -57.34% |
| Total Assets | -39.43% | -53.50% | -56.94% | -50.19% | -72.05% |
|
|
|||||
| Total Accounts Payable | -97.81% | 29.81% | 162.64% | 118.58% | 107.25% |
| Total Accrued Expenses | -81.36% | -67.30% | -69.57% | -52.80% | -38.04% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -94.26% | -25.53% | -6.74% | 68.80% | 32.74% |
| Total Other Current Liabilities | -94.26% | -25.53% | -6.74% | 68.80% | 32.74% |
| Total Current Liabilities | -92.06% | -23.20% | -22.05% | 6.52% | 13.79% |
|
|
|||||
| Total Current Liabilities | -92.06% | -23.20% | -22.05% | 6.52% | 13.79% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -57.14% | -- | -- | -92.42% | -73.75% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -91.97% | -23.54% | -22.55% | -36.40% | -29.73% |
|
|
|||||
| Common Stock & APIC | 3.16% | 1.96% | 1.87% | 3.01% | 1.56% |
| Retained Earnings | -2.14% | -2.62% | -3.18% | -4.09% | -4.68% |
| Treasury Stock & Other | 100.11% | 1.87% | 11.56% | 16.59% | 26.63% |
| Total Common Equity | 238.80% | -458.15% | -122.57% | -80.55% | -121.74% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 238.80% | -458.15% | -122.57% | -80.55% | -121.74% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 238.80% | -458.15% | -122.57% | -80.55% | -121.74% |
|
|
|||||